Lung Carcinoma: Advances in Understanding and Treatment
*Corresponding Author:Received Date: Nov 01, 2024 / Published Date: Nov 30, 2024
Copyright: © 0 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Lung carcinoma, one of the leading causes of cancer-related mortality worldwide, has seen significant advancements in understanding its underlying mechanisms and improving treatment options. This article reviews the current landscape of lung cancer research, focusing on the epidemiology, molecular biology, and risk factors associated with the disease. We explore recent breakthroughs in targeted therapies and immunotherapy that have transformed treatment paradigms, particularly for non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC). Additionally, the role of precision medicine and liquid biopsies in enhancing early diagnosis and monitoring treatment response is highlighted. By synthesizing these developments, this article aims to provide a comprehensive overview of lung carcinoma, underscoring the importance of ongoing research and innovation in improving patient outcomes and survival rates.
